Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Byetta for weight loss in morbidly obese patients after gastric banding
NCT00872378Phase 3Unknown
- Sponsor
- Advanced Specialty Care
- Start
- Feb 2009
- Primary completion
- Dec 2010
- Countries
- 1
01
Overview
A Phase 3 trial of exenatide in class III obesity, sponsored by Advanced Specialty Care. Status: unknown.
02
Drugs
exenatide
03
Conditions
class III obesity
Beyond the preview
Go deeper on NCT00872378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872378.